Table S5 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy

Synergy scores obtained from LSCC cell lines treated with co-treatment with NCB-0846 and cisplatin/etoposide. Cell viability was evaluated at 48h post-treatment.